Skip to content
    FF
    Earnings call· Jun 2026(Q2 FY26)

    FutureFuel Q2 FY26 earnings call FF

    Aug 11, 2026 Source

    Executive summary

    FutureFuel Q2 FY26 — Return to Profitable Growth Driven by Strong Demand and Regulatory Clarity

    FutureFuel returned to profitable growth in Q2 FY26, driven by robust demand in both chemicals and biofuels, improved plant reliability, and favorable regulatory changes for biofuels. The company is focused on commercial growth, operational excellence, and disciplined capital allocation, leveraging its integrated Batesville complex and long-term contract manufacturing model. Management is committed to increased transparency and investor engagement going forward.

    Highlights

    5
    • Total revenue increased 120.7% year-over-year to $78.7 million in Q2 FY26.

    • Total gross profit was $15 million in Q2 FY26, a significant improvement from a $12.4 million gross loss in the prior year period.

    • Adjusted EBITDA reached $11.8 million in Q2 FY26, compared to an $11.4 million loss in Q2 FY25.

    • Net cash flow from operations was $18.8 million in Q2 FY26, up from $5.2 million in the prior year.

    • Secured a 4-year agreement to monetize 45Z tax credits, expecting $22 million in gross proceeds in H2 2026.

    Concerns

    3
    • Elevated raw material input costs, particularly for soybean oil, continue to represent a near-term headwind for the Biofuels segment.

    • The Biofuels segment experienced a more than 3-week plant outage during Q2 FY26.

    • Chemical segment capacity utilization, while improved, stood at 65% in Q2 FY26, indicating room for further optimization.

    Guidance & targets

    5
    CategoryTargetConfidence
    Adjusted EBITDA
    positive
    high materiality
    High
    Biofuel production rates
    exceed second quarter levels
    medium materiality
    High
    45Z credit monetization proceeds
    $22 million gross
    high materiality
    High
    45Z credit monetization proceeds
    $3 million
    medium materiality
    High
    45Z credit monetization proceeds
    $19 million
    medium materiality
    High

    Segment performance

    2
    SegmentRevenueYoYQoQMargin
    Chemicals
    Revenue increased compared to $16.6 million in Q2 FY25. Improvement driven by increased sales volumes in the energy market, new product revenue from Q4 FY25, and increased fixed price absorption from improved biofuel volumes. Market conditions continued to improve with higher pricing and a growing project pipeline.
    Volume product mix effects: 49% increaseAverage prices: 6% benefitCustom Chemical revenue: $18.5 million (up 30% YoY)Performance Chemical revenue: $7.3 million (up from $2.4 million YoY)Capacity utilization: 65% (Q2 FY26), up from 54% (Q2 FY25)Total chemical production capacity: 12% increase (LTM)
    $25.8 million$5 million gross profit
    Biofuels
    Revenue increased compared to $19.1 million in Q2 FY25. Gross profit improved significantly from a $13.5 million gross loss in Q2 FY25. Driven by increased regulatory clarity surrounding clean fuel production credit and record high RVO levels. Benefited from higher sales volumes and stronger price realization, despite a >3-week plant outage. Elevated input costs partially offset favorable pricing.
    Capacity utilization: 56% (Q2 FY26)
    $52.9 million$10.1 million gross profit

    Operational metrics

    19
    Total production increase
    26%year-over-year
    Q2 FY26

    Supported by broad-based demand growth across specialty chemicals and biofuels.

    Total volume growth
    40.4%
    Q2 FY26

    Contributed to the overall revenue increase.

    Average blended price increase
    80.2%
    Q2 FY26

    Contributed to the overall revenue increase.

    Gross profit benefit from physical inventory sale
    $9.1 million
    Q2 FY26

    Related to the sale of physical inventory at prices above hedge levels, fully offsetting realized derivative losses from Q1 FY26.

    Realized derivative losses offset
    $9.1 million
    Q2 FY26

    Recognized during Q1 FY26, offset by Q2 FY26 physical inventory sale benefit.

    Unrealized derivative gains
    $3.2 million
    Q2 FY26

    Benefited gross profit during the second quarter.

    Net income
    $11.4 millionversus a net loss of $14.2 million in Q2 FY25
    Q2 FY26

    Reflects the return to profitable growth.

    Adjusted EBITDA
    $11.8 millionversus a loss of $11.4 million in Q2 FY25
    Q2 FY26

    Strong improvement reflecting operational and market tailwinds.

    Capital expenditures
    $8 million
    Q2 FY26

    Total capital expenditures for the quarter.

    Capital expenditures
    $13.4 million
    H1 FY26

    Total capital expenditures for the first six months of the fiscal year.

    Customer-funded investments (capex)
    $1.9 million
    Q2 FY26

    Part of discretionary capital expenditures, related to capacity expansions and new customer programs.

    Customer-funded investments (capex)
    $3.5 million
    H1 FY26

    Part of discretionary capital expenditures, related to capacity expansions and new customer programs.

    Cash and cash equivalents
    $34.3 millionup from $22.4 million at March 31, 2026
    as of June 30, 2026

    Increase driven by operating profit and customer funding, partially offset by working capital and capex.

    Revolving credit facility
    $35 millionno outstanding borrowing
    as of June 30, 2026

    Indicates strong liquidity position.

    Biodiesel plant outage duration
    more than 3 weeks
    Q2 FY26

    Impacted biofuel production during the quarter.

    RFS blending mandates increase
    60%over 2025
    2027

    New mandates issued by the EPA, expected to benefit domestic biofuels production.

    45Z credit extension
    2 years
    through year-end 2029

    Expanded guidance from the U.S. Treasury Department and IRS.

    45Z credit for SAF reduction
    $1.00from $1.75/gallon
    effective January 1, 2026

    Rule expected to help level the competitive environment for biodiesel.

    Working capital requirements
    increased
    Q2 FY26

    Related to new program activity, partially offset cash increase.

    Deals & partnerships

    1
    third partyMonetization of Section 45Z clean fuel production and small producer tax credits4-year agreement

    Agreement consistent with focus on balance sheet optimization.

    Capital programs

    1
    Customer-funded capacity expansionunderway$40 million
    Period spend: $1.9 million (Q2 FY26), $3.5 million (H1 FY26)
    Funding: customer-funded

    Benefit: incremental capacity (doubling or tripling capacity for one expansion)

    Agreement with a customer to fund an investment over the next 3 years to support incremental capacity, reflecting the company's contract manufacturing model.

    Risks & headwinds

    3
    Elevated raw material input costsnear-term

    Elevated input costs for soybean oil and other raw materials

    Mitigation: Expectation of reversion to mean values due to increased crush capacity and record harvests; focus on feedstock optionality.

    Biodiesel plant outageQ2 FY26

    More than 3-week biodiesel plant outage

    Mitigation: Ongoing focus on plant reliability and operational excellence.

    Economic shocks

    Not quantified

    Mitigation: Focus on operational excellence, disciplined capital allocation, and long-term customer relationships to build resilience.

    What to watch in Q3 FY26

    5

    Biofuel production rates

    Q3 FY26
    CurrentExceeded Q1 levels
    TargetExceed Q2 levels

    Why it matters

    Indicates continued operational ramp-up and market response to favorable regulatory environment in the Biofuel segment.

    Our biodiesel production continues to ramp higher with third quarter production rates expected to exceed second quarter levels.

    Q&A highlights

    5

    Where is FutureFuel in its plant performance improvement cycle, and are there more optimization initiatives planned?

    Roeland Polet stated they are about 60% to 70% of the way through securing important infrastructure, with the next phase focusing on efficiency investments based on payback analysis.

    I'd say we're about 60% of the way -- 60% to 70% of the way there on really going after the most important infrastructure to make sure it's secure, to make sure it's dependable. And then our next step will be driving investment into efficiency.

    asked by Jeffrey Grampp · answered by Roeland Polet

    2 min read6 chapters

    Detailed Narrative

    01

    Company Reintroduction & Strategic Shift

    FutureFuel, a 100% U.S.-based manufacturer with specialty chemicals and biofuels segments, is re-engaging with investors after a decade. CEO Roeland Polet, who joined in late 2024, has focused on strengthening the company's foundation and developing a clear roadmap for profitable growth and long-term value creation. The resumption of quarterly investor calls signals a commitment to greater transparency and consistent engagement with the investment community.

    02

    Batesville Complex as Competitive Advantage

    The company's 2,200-acre integrated manufacturing complex in Batesville, Arkansas, is highlighted as a primary competitive advantage. This site, with 50 years of complex chemical manufacturing history, offers state-of-the-art laboratories, engineering resources, flexible manufacturing units, wastewater treatment, and logistics infrastructure. This 'one-stop shop' solution is difficult to replicate and positions FutureFuel as an attractive partner for chemical customers seeking to mitigate supply chain risks from overseas sourcing.

    03

    Addressing Past Operational and Regulatory Challenges

    Over the past two years, FutureFuel has made significant strides in improving plant reliability through high-impact capital projects, enhancing site safety, and driving higher utilization. The biofuels business received much-needed regulatory clarity with new EPA RFS volume mandates (60% increase over 2025) and expanded 45Z credit guidance, extending the credit through 2029 and adjusting SAF credits. While plant reliability and regulatory environments have improved, elevated raw material input costs remain a focus area.

    04

    Three Pillars for Value Creation

    FutureFuel's value-creation roadmap is built on three key pillars: commercial growth, operational excellence, and a return-centric approach to capital allocation. Commercial growth focuses on increasing penetration of existing accounts, converting development products to commercial production, and expanding into adjacent markets. Operational excellence aims to improve cost efficiency, utilization, and safety across the Batesville complex. Capital allocation prioritizes organic reinvestment, customer-funded capacity expansions, opportunistic M&A, and balanced shareholder returns through dividends and share repurchases.

    05

    Contract Manufacturing Business Model

    The chemical business primarily operates on a contract manufacturing model, where customers leverage FutureFuel's site, permitting, and infrastructure to build and operate 'production cells.' This model reduces capital costs and execution risk for customers, leading to long-term, sticky relationships, with top customer relationships averaging over 15-20 years. New projects typically involve 1.5 to 2-year lead times from initiation to commercial production.

    06

    Biofuels Regulatory Tailwinds and Market Dynamics

    The Biofuels segment is benefiting from a favorable regulatory environment, including record-high RVO levels and the extension of the 45Z clean fuel production credit. These changes incentivize domestic production and are expected to drive existing U.S. domestic biofuels production to peak capacity by 2027. Despite a Q2 plant outage and elevated input costs, the segment saw meaningful improvement in gross profit, supported by higher sales volumes and stronger price realization.

    AI-generated summary of the company’s earnings call. Not investment advice.